RecruitingNCT06644976

Monitoring Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery Without Waiting. We Measure Bleeding in Surgery and the Levels of Noac Drug in Blood. We Will Try to Compare to Regular Pateints Later

Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery


Sponsor

Meir Hospital, Kfar Saba, Israel

Enrollment

100 participants

Start Date

Aug 20, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

until today we waited at least 24 hours before surgery of femoral neck fractures in patients who take anticouagolation . in our new reasearch we belive that patients who take NOAC can go under surgery earlier with minimal risk


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • above 18 y.o femoral neck fracture NOAC capable of making inform consent primary surgery
  • \-

Exclusion Criteria7

  • under 18 y.o
  • anti platelet therapy (aspirin is not included)
  • creatinine clearance under 50
  • active anti cancer therapy
  • ITP patients
  • non capable of making inform consent
  • patients which decide not to proceed with the expeirment

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREfemoral neck CRIF

femoral neck fracture CRiF while under noac. no special intervention beside taking blood test for drug levels


Locations(1)

Meir Hospital

Kfar Saba, Israel

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06644976


Related Trials